Synapse Medicine
French tech company | Builders Republic
Formerly Synapse Medecine
About
Clinical decision support platform that helps prescribers and EHR vendors make safer medication decisions — embedding AI-driven drug database aggregation, controlled substance workflows, and multi-factor authentication directly into existing e-prescribing systems via React Native components and APIs.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series B
- Founded
- 2017
- City
- BORDEAUX
- Region
- Nouvelle Aquitaine
- Legal name
- SYNAPSE MEDICINE
- SIREN
- 827466590
- Tracked rounds
- 2
- Amount raised
- 32 M€ raised since 2020
Funding rounds
- Series B — 2022
- Series A — 2020
Investors
- BNP Paribas Développement
- bpifrance
- Kima Ventures
- Korelya Capital
- MACSF
- Mutuelle d'Assurances du Corps de Santé Français
- XAnge
Notes
Renommée (ex-Synapse Médecine, opère sous Synapse Medicine)